Jan 28 – Jan 30, 2019
Omni Shoreham Hotel
2500 Calvert Street NW,
Washington, DC 20008
DIA’s Pharmacovigilance and Risk Management Strategies Conference is a leading forum for updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies. The content is developed by top experts from the biopharmaceutical industry and global regulatory agencies, including thought leaders from around the world to discuss the current challenges and issues in PV and Risk Management.
This year, regulators and industry experts will take an in-depth look at global harmonization of ICH E19, addressing optimization of safety data collection. Insights and forward-thinking approaches to pharmacovigilance and risk management to ensure the safety of existing as well as advanced new therapies as these enter development and the post-market setting will be discussed. Projects applying cutting edge technologies like machine learning/artificial intelligence to manage large volumes of potential safety data will be examined.